Tagged Articles

hip implant 241 articles

FDA asks artificial hip makers to report problems with metal devices

The Food and Drug Administration (FDA) is asking manufacturers of metal-on-metal artificial hips to report any problems with the implants, especially problems caused when bits of metal fall into the soft tissue around the implant caused by the rubbing together of the metal parts. The request comes less than a year after the FDA announced a recall of DePuy Orthopaedics ASR hip replacement system after reports that the device was failing at a higher than expected rate requiring patients to have revision surgery to replace the implant. The recall has left DePuy, a subsidiary of Johnson & Johnson, the focus ... Read More

U.K. DePuy hip patients deal with debilitating pain, long waiting lists

A lawyer representing some 300 recipients of DePuy artificial hips in the U.K. says that for her clients and many other patients throughout the country waiting to have the devices removed, “the damage has already been done.” Liverpool solicitor Lisa Lunt told the Liverpool Daily Post that several of her clients have been so damaged by the recalled hip devices that they will likely never experience the quality of life that the DePuy implants once promised. “The large majority of my clients are really suffering terrible pain, some now have walking aids,” Ms. Lunt told the Liverpool Daily Post. “One ... Read More

Employee benefits fund files suit against artificial hip maker

A fund that manages health benefits for 25 towns in northern New Jersey has filed a civil lawsuit in U.S. District Court alleging that medical device manufacturer DePuy Orthopaedics continued to market its ASR hip replacement system in the United States even after learning that the device was defective and causing patients unnecessary pain and suffering. The North Jersey Municipal Employee Benefits Fund filed the class action lawsuit last month, and is asking the court to order DePuy to cover any of its members who may have been affected by the recall of the faulty device as well as allow the ... Read More

After 5 surgeries, woman files lawsuit against artificial hip maker

Jane Rogers had no choice but to have total hip replacement surgeries on both hips. Her hip joints were badly damaged because of osteoarthritis. But she should have never had to endure the three hip surgeries that followed soon after. Rogers’ artificial hips failed prematurely, leaving her in more pain and more disabled than she was before surgery. She is just one of more than 1,000 people who has filed a lawsuit against the makers of the defective hip replacement systems, DePuy Orthopaedics. Nearly 100,000 people worldwide are affected by the DePuy artificial hip recall. More than a third of ... Read More

Databases established in wake of hip implant recall

Two separate databases are now tracking the success rates of artificial hips and knees in the United States, following the recall of 93,000 hip replacement systems by DuPuy Orthopaedics, a subsidiary of Johnson & Johnson, during which it was discovered no such database existed in America. One database is organized by the orthopedic industry and the other is funded by the federal government. The registries aim not only to fill the void in the United States, but to improve upon databases currently in use in Australia, Sweden and other countries. The need for such a database came into the forefront ... Read More

Major league umpire wins lawsuit against artificial hip manufacturer

Former major league umpire Mark Hirschbeck has agreed to settle a multi-million dollar lawsuit against the manufacturer of his artificial hip. Hirschbeck sued the hip implant maker after his device shattered while he was sitting and watching TV. The injury caused an infection and required four additional surgeries, which left the umpire disabled at age 42 and unable to continue working in his $350,000-a-year umpire job. Hirschbeck’s settlement was with Wright Medical Technology of Arlington, Tenn., and was reached before Superior Court Judge Barbara Bellis just as the case was set to go to trial. The terms of the agreement ... Read More

Amid sea of recalls, J and J considers takeover of medical device company

Johnson & Johnson is reportedly in talks with device maker Synthes Inc. about a possible takeover, potentially the biggest deal in Johnson & Johnson’s 125-year history. Synthes has a market value of about $19 billion, and a takeover of the company could give Johnson & Johnson just what it needs deflect the negative press it has received over the past year from recalled products that range from over-the-counter medicines and consumer products to artificial hip implants. Synthes is the largest maker of devices to treat bone fractures and trauma. Merging with Synthes’ Smith & Nephew Plc. would add more trauma products ... Read More

Hip-replacement hospital re-admissions rise

A study published in the Journal of American Medical Association found that hospital readmission rates rose significantly in recent years for patients who underwent total hip replacement surgery. The study’s authors analyzed data on 1.45 million Medicare recipients who had total hip replacements from 1991 to 2008 and approximately 328,000 Medicare patients who required a second hip-replacement “revision” surgery. From 2007 to 2008, 8.5 percent of total-hip-surgery patients were readmitted to the hospital within 30 days of being discharged, a rise of more than 2.5 percent in previous years. Although the study does not offer specific explanations for the increase, ... Read More

Rate of hospital readmissions increases for artificial hip recipients

The average length of a hospital stay for patients who have hip replacement surgery has dropped considerably in recent years, but the rate of readmissions for complications or referrals to nursing homes has increased, according to a new study. Researchers reviewed 1.5 million Medicare Part A beneficiaries who underwent primary total hip replacement surgery between 1991 and 2008, and 348,596 people who underwent revision surgery, or surgery to replace an artificial hip. The average length of hospital stay for primary hip replacement patients dropped from 9.1 days during the first two years of the study to 3.7 days during the ... Read More

Many medical devices approved without human testing

About one percent of medical devices introduced in the United States market get recalled. It seems like a small number, but that number represents thousands of people who have died or been harmed by faulty medical devices. The clincher? Many of those devices were never tested on humans before they were approved for use. The process is called fast-tracking. Some categories of medical devices can be approved by the Food and Drug Administration (FDA) with little or no testing if they are similar to other devices already approved. Since 2009, 67 individual high-risk devices have been approved through this process ... Read More